Karen Reckamp, MD, MS
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer (NCT05401110) | Karen Reckamp, MD, MS | 2023-09-15 |
Track Karen Reckamp, MD, MS automatically
Every clearance here is in the API, with alerts when new ones post.